Darya Chudova - Jun 1, 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Stock symbol
GH
Transactions as of
Jun 1, 2023
Transactions value $
-$26,226
Form type
4
Date filed
9/5/2023, 05:59 PM
Previous filing
May 15, 2023
Next filing
Aug 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +316 +2.54% $0.00 12.7K Jun 1, 2023 Direct
transaction GH COMMON STOCK Tax liability -$3.45K -110 -0.86% $31.39 12.6K Jun 1, 2023 Direct F1
transaction GH COMMON STOCK Options Exercise $0 +1.44K +11.4% $0.00 14.1K Aug 1, 2023 Direct
transaction GH COMMON STOCK Tax liability -$18.9K -498 -3.54% $38.00 13.6K Aug 1, 2023 Direct F1
transaction GH COMMON STOCK Options Exercise $0 +316 +2.33% $0.00 13.9K Sep 1, 2023 Direct
transaction GH COMMON STOCK Tax liability -$3.85K -110 -0.79% $35.01 13.8K Sep 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -316 -10.01% $0.00 2.84K Jun 1, 2023 COMMON STOCK 316 $0.00 Direct F2, F3
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -1.44K -100% $0.00* 0 Aug 1, 2023 COMMON STOCK 1.44K $0.00 Direct F3, F4
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -316 -11.12% $0.00 2.53K Sep 1, 2023 COMMON STOCK 316 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025.
F3 Not applicable for Restricted Stock Units.
F4 The restricted stock unit award was granted on August 1, 2019, of which 1,440 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares will vest on August 1, 2023.